{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T18:34:50Z","timestamp":1692470090861},"reference-count":37,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1547,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1111\/j.1744-313x.2011.01017.x","type":"journal-article","created":{"date-parts":[[2011,6,7]],"date-time":"2011-06-07T11:15:19Z","timestamp":1307445319000},"page":"383-387","source":"Crossref","is-referenced-by-count":3,"title":["Do complement factor H 402Y and C7 M allotypes predispose to (typical) haemolytic uraemic syndrome?"],"prefix":"10.1111","volume":"38","author":[{"given":"K.","family":"Poolpol","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Gadner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Neururer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Mellmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Karch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Orth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"W\u00fcrzner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,6,7]]},"reference":[{"key":"10.1111\/j.1744-313X.2011.01017.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1084\/jem.20070664","article-title":"Complement factor H and the hemolytic uremic syndrome","volume":"204","author":"Atkinson","year":"2007","journal-title":"Journal of Experimental Medicine"},{"key":"10.1111\/j.1744-313X.2011.01017.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1182\/blood-2008-03-146472","article-title":"C7 is expressed on endothelial cells as a trap for the assembling terminal complement complex and may exert anti-inflammatory function","volume":"113","author":"Bossi","year":"2009","journal-title":"Blood"},{"key":"10.1111\/j.1744-313X.2011.01017.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1681\/ASN.V122297","article-title":"The molecular basis of familial hemolytic uremic syndrome: mutation analysis of factor H gene reveals a hot spot in short consensus repeat 20","volume":"12","author":"Caprioli","year":"2001","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1111\/j.1744-313X.2011.01017.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"3385","DOI":"10.1093\/hmg\/ddg363","article-title":"Complement factor H mutations and gene polymorphisms in haemolytic uraemic syndrome: the C-257T, the A2089G and the G2881T polymorphisms are strongly associated with the disease","volume":"12","author":"Caprioli","year":"2003","journal-title":"Human Molecular Genetics"},{"key":"10.1111\/j.1744-313X.2011.01017.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/BF00346588","article-title":"Sequence polymorphism of human complement factor H","volume":"27","author":"Day","year":"1988","journal-title":"Immunogenetics"},{"key":"10.1111\/j.1744-313X.2011.01017.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"17087","DOI":"10.1016\/S0021-9258(18)41897-2","article-title":"Formation and structure of the C5b-7 complex of the lytic pathway of complement","volume":"267","author":"DiScipio","year":"1992","journal-title":"Journal of Biological Chemistry"},{"key":"10.1111\/j.1744-313X.2011.01017.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1681\/ASN.2004050380","article-title":"Anti-factor H autoantibodies associated with atypical hemolytic uremic syndrome","volume":"16","author":"Dragon-Durey","year":"2005","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1111\/j.1744-313X.2011.01017.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1126\/science.1110189","article-title":"Complement factor H polymorphism and age-related macular degeneration","volume":"308","author":"Edwards","year":"2005","journal-title":"Science"},{"key":"10.1111\/j.1744-313X.2011.01017.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.ophtha.2003.07.012","article-title":"Age-related macular degeneration causing visual impairment in people 75\u2003years or older in Britain: an add-on study to the Medical Research Council Trial of Assessment and Management of Older People in the Community","volume":"111","author":"Evans","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1111\/j.1744-313X.2011.01017.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1001\/archopht.122.4.564","article-title":"Prevalence of age-related macular degeneration in the United States","volume":"122","author":"Friedman","year":"2004","journal-title":"Archives of Ophthalmology"},{"key":"10.1111\/j.1744-313X.2011.01017.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/j.1365-2958.2008.06347.x","article-title":"Complement factor H allotype 402H is associated with increased C3b opsonization and phagocytosis of Streptococcus pyogenes","volume":"70","author":"Haapasalo","year":"2008","journal-title":"Molecular Microbiology"},{"key":"10.1111\/j.1744-313X.2011.01017.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"7227","DOI":"10.1073\/pnas.0501536102","article-title":"A common haplotype in the complement regulatory gene factor H (HF1\/CFH) predisposes individuals to age-related macular degeneration","volume":"102","author":"Hageman","year":"2005","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1111\/j.1744-313X.2011.01017.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1126\/science.1110359","article-title":"Complement factor H variant increases the risk of age-related macular degeneration","volume":"308","author":"Haines","year":"2005","journal-title":"Science"},{"key":"10.1111\/j.1744-313X.2011.01017.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1182\/blood-2007-02-071472","article-title":"Anti factor H autoantibodies block C-terminal recognition function of factor H in hemolytic uremic syndrome","volume":"110","author":"Jozsi","year":"2007","journal-title":"Blood"},{"key":"10.1111\/j.1744-313X.2011.01017.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.ijmm.2005.06.009","article-title":"Enterohaemorrhagic Escherichia coli in human medicine","volume":"295","author":"Karch","year":"2005","journal-title":"International Journal of Medical Microbiology"},{"key":"10.1111\/j.1744-313X.2011.01017.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1126\/science.1109557","article-title":"Complement factor H polymorphism in age-related macular degeneration","volume":"308","author":"Klein","year":"2005","journal-title":"Science"},{"key":"10.1111\/j.1744-313X.2011.01017.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1093\/rheumatology\/26.6.409","article-title":"Heberden oration 1986. Complement - friend or foe","volume":"26","author":"Lachmann","year":"1987","journal-title":"British Journal of Rheumatology"},{"key":"10.1111\/j.1744-313X.2011.01017.x-BIB18|cit18","first-page":"168","article-title":"The complement system in hemolytic-uremic syndrome in childhood","volume":"13","author":"Monnens","year":"1980","journal-title":"Clinical Nephrology"},{"key":"10.1111\/j.1744-313X.2011.01017.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.diagmicrobio.2007.04.013","article-title":"The Shiga toxin genotype rather than the amount of Shiga toxin or the cytotoxicity of Shiga toxin in vitro correlates with the appearance of the hemolytic uremic syndrome","volume":"59","author":"Orth","year":"2007","journal-title":"Diagnostic Microbiology and Infectious Disease"},{"key":"10.1111\/j.1744-313X.2011.01017.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"6394","DOI":"10.4049\/jimmunol.0900151","article-title":"Shiga toxin activates complement and binds factor H: evidence for an active role of complement in hemolytic uremic syndrome","volume":"182","author":"Orth","year":"2009","journal-title":"Journal of Immunology"},{"key":"10.1111\/j.1744-313X.2011.01017.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1086\/318201","article-title":"Clustering of missense mutations in the C-terminal region of factor H in atypical hemolytic uremic syndrome","volume":"68","author":"Perez-Caballero","year":"2001","journal-title":"American Journal of Human Genetics"},{"key":"10.1111\/j.1744-313X.2011.01017.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1086\/318203","article-title":"Factor H mutations in hemolytic uremic syndrome cluster in exons 18-20, a domain important for host cell recognition","volume":"68","author":"Richards","year":"2001","journal-title":"American Journal of Human Genetics"},{"key":"10.1111\/j.1744-313X.2011.01017.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.2007.03552.x","article-title":"Translational mini-review series on complement factor H: genetics and disease associations of human complement factor H","volume":"151","author":"Rodriguez de Cordoba","year":"2008","journal-title":"Clinical and Experimental Immunology"},{"key":"10.1111\/j.1744-313X.2011.01017.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/humu.20435","article-title":"The interactive factor H-atypical hemolytic uremic syndrome mutation database and website: update and integration of membrane cofactor protein and Factor I mutations with structural models","volume":"28","author":"Saunders","year":"2007","journal-title":"Human Mutation"},{"key":"10.1111\/j.1744-313X.2011.01017.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1007\/s00467-008-0935-6","article-title":"Treatment and outcome of Shiga-toxin-associated hemolytic uremic syndrome (HUS)","volume":"23","author":"Scheiring","year":"2008","journal-title":"Pediatric Nephrology"},{"key":"10.1111\/j.1744-313X.2011.01017.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1160\/TH08-05-0322","article-title":"Autoantibodies in haemolytic uraemic syndrome (HUS)","volume":"101","author":"Skerka","year":"2009","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1111\/j.1744-313X.2011.01017.x-BIB27|cit27","volume-title":"Fundamental Immunology","author":"Speth","year":"2008"},{"key":"10.1111\/j.1744-313X.2011.01017.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1469-1809.2009.00554.x","article-title":"Epidemiological approach to identifying genetic predispositions for atypical hemolytic uremic syndrome","volume":"74","author":"Sullivan","year":"2010","journal-title":"Annals of Human Genetics"},{"key":"10.1111\/j.1744-313X.2011.01017.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1093\/hmg\/ddl220","article-title":"Systematic review and meta-analysis of the association between complementary factor H Y402H polymorphisms and age-related macular degeneration","volume":"15","author":"Thakkinstian","year":"2006","journal-title":"Human Molecular Genetics"},{"key":"10.1111\/j.1744-313X.2011.01017.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.2215\/CJN.02730409","article-title":"Alternative pathway of complement in children with diarrhea-associated hemolytic uremic syndrome","volume":"4","author":"Thurman","year":"2009","journal-title":"Clinical Journal of the American Society of Nephrology"},{"key":"10.1111\/j.1744-313X.2011.01017.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/j.1523-1755.1998.00824.x","article-title":"Genetic studies into inherited and sporadic hemolytic uremic syndrome","volume":"53","author":"Warwicker","year":"1998","journal-title":"Kidney International"},{"key":"10.1111\/j.1744-313X.2011.01017.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1046\/j.1365-2249.2000.01263.x","article-title":"Modulation of complement membrane attack by local C7 synthesis","volume":"121","author":"W\u00fcrzner","year":"2000","journal-title":"Clinical and Experimental Immunology"},{"key":"10.1111\/j.1744-313X.2011.01017.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1159\/000463163","article-title":"C7*9, a new frequent C7 allele detected by an allotype-specific monoclonal antibody","volume":"7","author":"W\u00fcrzner","year":"1990","journal-title":"Complement and Inflammation"},{"key":"10.1111\/j.1744-313X.2011.01017.x-BIB34|cit34","first-page":"177","article-title":"C7*N is a hypomorphic allele of the human complement C7\u2003M\/N protein polymorphism","volume":"8","author":"W\u00fcrzner","year":"1991","journal-title":"Experimental and Clinical Immunogenetics"},{"key":"10.1111\/j.1744-313X.2011.01017.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/BF00179797","article-title":"A novel protein polymorphism of human complement C7 detected by a monoclonal antibody","volume":"35","author":"W\u00fcrzner","year":"1992","journal-title":"Immunogenetics"},{"key":"10.1111\/j.1744-313X.2011.01017.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"4813","DOI":"10.4049\/jimmunol.154.9.4813","article-title":"Molecular basis of the complement C7\u2003M\/N polymorphism. A neutral amino acid substitution outside the epitope of the allospecific monoclonal antibody WU 4-15","volume":"154","author":"W\u00fcrzner","year":"1995a","journal-title":"Journal of Immunology"},{"key":"10.1111\/j.1744-313X.2011.01017.x-BIB37|cit37","first-page":"61","article-title":"Complement C7\u2003M\/N allotyping in infectious diseases","volume":"12","author":"W\u00fcrzner","year":"1995b","journal-title":"Experimental and Clinical Immunogenetics"}],"container-title":["International Journal of Immunogenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1744-313X.2011.01017.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1744-313X.2011.01017.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T07:12:21Z","timestamp":1686121941000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1744-313X.2011.01017.x"}},"subtitle":["Complement factor H and C7 allotypes in HUS"],"short-title":[],"issued":{"date-parts":[[2011,6,7]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,10]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1744-313x.2011.01017.x","relation":{},"ISSN":["1744-3121"],"issn-type":[{"value":"1744-3121","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6,7]]}}}